Progyny, Inc. logo PGNY - Progyny, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 15
HOLD 5
SELL 0
STRONG
SELL
0
| PRICE TARGET: $30.33 DETAILS
HIGH: $35.00
LOW: $27.00
MEDIAN: $30.00
CONSENSUS: $30.33
DOWNSIDE: 1.46%

About Progyny, Inc. (https://www.progyny.com)

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.

Key Executives

NAME TITLE DOB SALARY
Peter Anevski Chief Executive Officer & Director 1967 $1,620,637 USD
Melissa Cummings Chief Operating Officer 1970 $1,346,151 USD
Mark S. Livingston Chief Financial Officer 1966 $880,386 USD
Geoffrey Clapp Chief Product Officer 1974 $661,810 USD
Allison Swartz Executive Vice President, General Counsel & Secretary 1990 $645,175 USD
David J. Schlanger Executive Chairman 1959 $468,168 USD
Cassandra Pratt Chief Human Resources Officer
James Hart Vice President of Investor Relations
Julie Stadlbauer Chief Business Development Officer
Risa Fisher Chief Marketing Officer
Steven Leist Chief Technology Officer

Company Peers

Peer analysis pending, check back in 1-2 minutes.